-
CX-4945 (Silmitasertib): CK2 Research Workflows
2026-09-15
CX-4945 (Silmitasertib) enables controlled studies of CK2-dependent survival signaling, apoptosis, and cell-cycle regulation. This workflow connects cancer-cell assays with a reference-study-inspired strategy for testing CK2 involvement in neuroinflammatory injury.
-
Balsalazide Prodrug Evidence in Ulcerative Colitis
2026-09-15
The 2009 review by Wiggins and Rajapakse describes balsalazide as a colon-targeted 5-aminosalicylate prodrug activated by bacterial azoreduction. Its synthesis of clinical evidence supports efficacy for remission induction in mild-to-moderate active ulcerative colitis, with rapid symptom improvement and tolerability comparable to other oral 5-ASA therapies.
-
Fluorescein Tyramide: 5 Lab Scenarios
2026-09-14
This scenario-based guide explains how Fluorescein Tyramide (SKU K1084) can strengthen low-abundance target detection in IHC, ISH, and flow cytometry workflows that complement cell viability, proliferation, and cytotoxicity studies. It separates product-supported handling parameters from laboratory recommendations and highlights controls needed for defensible interpretation.
-
Baicalin: Visual Plasticity and Bench Workflows
2026-09-14
Baicalin connects a validated adult-mouse visual-plasticity model with practical workflows for cortical imaging, electrophysiology, and mechanistic validation. Its formulation profile also supports carefully controlled cancer research studies involving oxidative stress, NSCLC sensitization, and TGF-β1/p-Smad3 pathway inhibition.
-
Bestatin (Ubenimex): Applied Research Workflows
2026-09-13
Bestatin (Ubenimex) is a practical probe for connecting aminopeptidase activity with cell signaling, multidrug resistance, apoptosis, and endothelial invasion. This workflow-focused guide explains how to control solvent, dose, matrix context, and assay interpretation for more reproducible results.
-
Lanabecestat: Precision in the BACE1 Dose Window
2026-09-12
Lanabecestat (AZD3293) provides a potent, brain-penetrant framework for studying BACE1-driven amyloid biology. This thought-leadership guide connects its molecular profile with evidence that partial amyloid-beta reduction may preserve synaptic transmission, offering translational researchers a strategy for exposure design, functional validation, and more disciplined Alzheimer’s disease research.
-
Caspase-3/7 Inhibitor I: Lab Guide
2026-09-12
A scenario-based guide to using Caspase-3/7 Inhibitor I (SKU A1925) for selective apoptosis modulation, pathway dissection, and caspase activity measurement. It covers formulation, controls, interpretation, and practical vendor-selection criteria for biomedical research workflows.
-
MRSA Extracellular Vesicles Drive IL-8 in Oral Cancer
2026-09-11
A 2026 study shows that extracellular vesicles from methicillin-resistant Staphylococcus aureus can actively promote oral squamous cell carcinoma growth through an IL-8-centered signaling circuit. By combining extracellular-vesicle uptake studies, cargo analysis, pathway inhibition, genetic IL-8 loss, and CXCR1 blockade in mice, the work connects antibiotic-resistant bacteria with tumor-cell proliferation and provides a framework for separating tumor-cell IL-8 signaling from neutrophil chemotaxis.
-
A23187, Free Acid: Calcium Ionophore Workflows
2026-09-11
A23187, free acid is a practical calcium ionophore for separating intracellular Ca2+ signaling from downstream growth arrest and cell death. This guide combines model-specific applications with time-resolved viability, apoptosis, calcium, and ROS workflows for more interpretable in vitro experiments.
-
Azilsartan: From AT1 Biology to Translation
2026-09-10
A mechanistic and strategic guide to using Azilsartan medoxomil monopotassium (TAK 491) in receptor pharmacology, blood pressure regulation studies, and translational cardiovascular research, with practical protocol guidance and interpretation of recent network meta-analysis evidence.
-
Sulfachloropyridazine: Reliable Lab Workflows
2026-09-10
This scenario-driven guide explains how Sulfachloropyridazine, SKU BA1082, can support DHPS inhibition studies, antimicrobial susceptibility testing, microbiome experiments, and carefully controlled cell-based workflows. It emphasizes solvent compatibility, assay controls, strain-dependent activity, and evidence-based interpretation rather than assuming that antimicrobial effects represent direct mammalian cytotoxicity.
-
Latrunculin A Workflows for Actin Studies
2026-09-09
Latrunculin A enables controlled, reversible actin perturbation for cytoskeleton disaggregation, migration assays, and host–virus studies. This practical guide translates recent VP26 interactome findings into concentration, timing, controls, and troubleshooting choices for reproducible experiments.
-
C34 TLR4 Inhibitor: Mechanistic Workflow
2026-09-09
C34 is a selective TLR4 inhibitor for separating TLR4-driven inflammation from broader innate immune activation. This workflow shows how to apply it in macrophage, enterocyte, necrotizing enterocolitis, and neuroinflammation research while preserving pathway specificity and assay reproducibility.
-
HIV Latency, Telomeres, and DNA Damage Response
2026-09-08
This study shows that HIV-1 infection and latency are associated with telomere elongation in primary memory CD4+ T cells and Jurkat-derived models. It further demonstrates that telomere-targeting treatment preferentially induces apoptosis in infected cultures, supporting DNA damage response and telomere maintenance as potential vulnerabilities of the HIV reservoir.
-
KR-12 Design, Mechanisms, and Translational Potential
2026-09-08
The 2024 review presents KR-12 as the smallest antibacterial fragment of human LL-37 and organizes how sequence, structure, engineering, delivery, and host-response data shape its potential use. Its central practical insight is that KR-12 is not only a membrane-active peptide, but also a platform for anti-biofilm, endotoxin-neutralizing, immunomodulatory, biomaterial, and animal-model studies.